Oxford University spin-out develops new test for heart disease
The CEO of a medtech spin-out from Oxford University has described how being paired with a group of experienced business mentors has helped his team commercialise a new way of diagnosing heart disease.
Founded by four Oxford cardiologists, Caristo Diagnostics has developed a new test that analyses routine heart scans for signs of inflammation in the coronary arteries, which supply blood to the heart. It’s known that inflammation in the coronary arteries is a key feature in the lead up to heart attacks.
You can read the write-up here.
AI awards help build evidence base for technologies – health secretary
In an exclusive column for Digital Health News, Secretary of State for Health and Social Care Steve Barclay says the…
THE BIOTECHNOLOGY BOOM IN OXFORD: A LOOK AT 15 EXCITING STARTUPS
Caristo Diagnostics Caristo Diagnostics is a startup that is using standard CT scans to identify potentially heart-stopping plaques. Their technology…